Indigo Therapeutics To Open Concentrated Cannabis Manufacturing Plant In Richmond, California
07/21/2016
According to company officials, Richmond City Council voted unanimously to grant the first license for the legal manufacture of concentrated cannabis in California to Indigo Therapeutics, a legal cannabis company owned by Landrace Venture Fund. The license allows Indigo to begin producing cannabis concentrates immediately in quantities that make the company the state's largest manufacturer of concentrates.
"We're thrilled about the opportunities this license opens to provide medical marijuana patients with legal, consistent, and pure concentrates and edibles," said Joe Hawayek of Indigo Therapeutics. Cannabis concentrates and edibles are the largest and fastest growing segments of the cannabis market. "Consumers will now be able to trust that their products are pure, consistent, and of the highest quality," said Hawayek.
Professional extraction and refinement establishes product purity, safety, and dosage control and promises to be the most valuable link in the supply chain for legal cannabis, officials said.
"We are excited that Landrace Ventures and Indigo are leading the way in Richmond," said the Mayor of Richmond, Tom Butt. "With the California legislature clarifying the State's legal context for cannabis cultivation and product manufacturing last year, cities can now proceed to issue permits for such operations without risk.”
"These businesses, when properly regulated and operated in designated locations, can be low impact and provide good jobs and revenue for the City of Richmond,” he added.
"We have worked closely with the City of Richmond and other local and state officials to ensure that all communities are heard and satisfied," said Hawayek. "Our goal is to bring professionalism to the marketplace and be the standard of quality and consistency."
Landrace Venture Fund was established earlier this year to invest in legal and scalable cannabis infrastructure. "We're looking carefully for opportunities in the medical and recreational markets," said Scott Lucas, one of the Fund's founding partners. "We see enormous potential for refined, quality-controlled cannabis in pharmaceuticals for chronic pain management, sleep, diet, epilepsy, arthritis, and as an alternative to over prescribed opioids."
Project Announcements
Vietnam-Based Boviet Solar Plans Greenville, North Carolina, Production Operations
05/01/2024
Nestlé Purina PetCare Company Expands Jefferson, Wisconsin, Operations
04/30/2024
Honda Motor Plans Alliston, Ontario, Canada, EV Production-Battery Operations
04/30/2024
Toyota Expand Princeton, Indiana, Assembly Operations
04/30/2024
Tradd Advisory Company Expands Mount Pleasant, South Carolina, Operations
04/29/2024
KOI Superior Walls Plans Boone County, Kentucky, Operations
04/29/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024